SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-005414
Filing Date
2016-03-09
Accepted
2016-03-09 16:33:40
Documents
60
Period of Report
2016-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT peregrine_10q-013116.htm 10-Q 423758
2 CERTIFICATION peregrine_10q-ex3101.htm EX-31.1 7800
3 CERTIFICATION peregrine_10q-ex3102.htm EX-31.2 8044
4 CERTIFICATION peregrine_10q-ex32.htm EX-32 5167
  Complete submission text file 0001019687-16-005414.txt   2911001

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20160131.xml EX-101.INS 619249
6 XBRL SCHEMA FILE pphm-20160131.xsd EX-101.SCH 31700
7 XBRL CALCULATION FILE pphm-20160131_cal.xml EX-101.CAL 51507
8 XBRL DEFINITION FILE pphm-20160131_def.xml EX-101.DEF 88998
9 XBRL LABEL FILE pphm-20160131_lab.xml EX-101.LAB 214425
10 XBRL PRESENTATION FILE pphm-20160131_pre.xml EX-101.PRE 176948
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 161494965
SIC: 2834 Pharmaceutical Preparations